ST. LOUIS, Aug. 16, 2021 /PRNewswire/ -- Centene
Corporation (NYSE: CNC) announced today Rich Fisher has been appointed to Senior Vice
President and Medicare CEO. Mr. Fisher will play a critical role
overseeing the Company's Medicare strategy, product development,
sales, and operations. He will report to Brent Layton, Executive Vice President and
President of U.S. Health Plans, Products, and International.
"At Centene, we continually look to promote our internal talent
into enhanced roles," said Mr. Layton. "I am pleased to announce
Rich has been selected to serve as our SVP, Medicare CEO. His
expertise and leadership will be invaluable as we continue to grow
our Medicare business and deliver on our commitments to our 2021
priorities."
Mr. Fisher joined Centene through the acquisition of Wellcare
and has more than 15 years in the combined organization. For the
past four years, he has served as Medicare's Chief Financial
Officer and has played an instrumental role in driving overall
growth and profitability for the Company's Medicare products. He
holds a bachelor's degree in business administration with
concentrations in finance and marketing from the University of Florida.
About Centene
Centene Corporation, a Fortune 25
company, is a leading multi-national healthcare enterprise that is
committed to helping people live healthier lives. The Company takes
a local approach – with local brands and local teams – to provide
fully integrated, high-quality, and cost-effective services to
government-sponsored and commercial healthcare programs, focusing
on under-insured and uninsured individuals. Centene offers
affordable and high-quality products to nearly 1 in 15 individuals
across the nation, including Medicaid and Medicare members
(including Medicare Prescription Drug Plans) as well as individuals
and families served by the Health Insurance Marketplace, the
TRICARE program, and individuals in correctional facilities. The
Company also serves several international markets, and contracts
with other healthcare and commercial organizations to provide a
variety of specialty services focused on treating the whole person.
Centene focuses on long-term growth and the development of its
people, systems and capabilities so that it can better serve its
members, providers, local communities, and government partners.
Forward-Looking Statements
All statements, other than
statements of current or historical fact, contained in this press
release are forward-looking statements. Without limiting the
foregoing, forward-looking statements often use words such as
"believe," "anticipate," "plan," "expect," "estimate," "intend,"
"seek," "target," "goal," "may," "will," "would," "could,"
"should," "can," "continue" and other similar words or expressions
(and the negative thereof). Centene (the Company, our, or we)
intends such forward-looking statements to be covered by the
safe-harbor provisions for forward-looking statements contained in
the Private Securities Litigation Reform Act of 1995, and we are
including this statement for purposes of complying with these
safe-harbor provisions. In particular, these statements include,
without limitation, statements about our future operating or
financial performance, market opportunity, growth strategy,
competition, expected activities in completed and future
acquisitions, including statements about the impact of our proposed
acquisition of Magellan Health (the Magellan Acquisition), our
completed acquisition of WellCare Health Plans, Inc. (WellCare and
such acquisition, the WellCare Acquisition), other recent and
future acquisitions, investments, the adequacy of our available
cash resources and our settlements with Ohio and Mississippi to resolve claims and/or
allegations made by those states with regard to past practices at
Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy
benefits manager (PBM) subsidiary, and other possible future claims
and settlements related to the past practices at Envolve and our
ability to settle claims with other states within the reserve
estimate we have recorded and on other acceptable terms, or at all.
These forward-looking statements reflect our current views with
respect to future events and are based on numerous assumptions and
assessments made by us in light of our experience and perception of
historical trends, current conditions, business strategies,
operating environments, future developments and other factors we
believe appropriate. By their nature, forward-looking statements
involve known and unknown risks and uncertainties and are subject
to change because they relate to events and depend on circumstances
that will occur in the future, including economic, regulatory,
competitive and other factors that may cause our or our industry's
actual results, levels of activity, performance or achievements to
be materially different from any future results, levels of
activity, performance or achievements expressed or implied by these
forward-looking statements. These statements are not guarantees of
future performance and are subject to risks, uncertainties and
assumptions. All forward-looking statements included in this press
release are based on information available to us on the date
hereof. Except as may be otherwise required by law, we undertake no
obligation to update or revise the forward-looking statements
included in this press release, whether as a result of new
information, future events or otherwise, after the date hereof. You
should not place undue reliance on any forward-looking statements,
as actual results may differ materially from projections,
estimates, or other forward-looking statements due to a variety of
important factors, variables and events including, but not limited
to: the impact of COVID-19 on global markets, economic conditions,
the healthcare industry and our results of operations and the
response by governments and other third parties; the risk that
regulatory or other approvals required for the Magellan Acquisition
may be delayed or not obtained or are subject to unanticipated
conditions that could require the exertion of management's time and
our resources or otherwise have an adverse effect on us; the
possibility that certain conditions to the consummation of the
Magellan Acquisition will not be satisfied or completed on a timely
basis and accordingly, the Magellan Acquisition may not be
consummated on a timely basis or at all; uncertainty as to the
expected financial performance of the combined company following
completion of the Magellan Acquisition; the possibility that the
expected synergies and value creation from the Magellan Acquisition
or the WellCare Acquisition (or other acquired businesses) will not
be realized, or will not be realized within the respective expected
time periods; the risk that unexpected costs will be incurred in
connection with the completion and/or integration of the Magellan
Acquisition or that the integration of Magellan Health will be more
difficult or time consuming than expected; the risk that potential
litigation in connection with the Magellan Acquisition may affect
the timing or occurrence of the Magellan Acquisition or result in
significant costs of defense, indemnification and liability; a
downgrade of the credit rating of our indebtedness; the inability
to retain key personnel; disruption from the announcement,
pendency, completion and/or integration of the Magellan Acquisition
or from the integration of the WellCare Acquisition, or similar
risks from other acquisitions we may announce or complete from time
to time, including potential adverse reactions or changes to
business relationships with customers, employees, suppliers or
regulators, making it more difficult to maintain business and
operational relationships; our ability to accurately predict and
effectively manage health benefits and other operating expenses and
reserves, including fluctuations in medical utilization rates due
to the impact of COVID-19; competition; membership and revenue
declines or unexpected trends; changes in healthcare practices, new
technologies and advances in medicine; increased healthcare costs;
changes in economic, political or market conditions; changes in
federal or state laws or regulations, including changes with
respect to income tax reform or government healthcare programs as
well as changes with respect to the Patient Protection and
Affordable Care Act and the Health Care and Education Affordability
Reconciliation Act (collectively referred to as the ACA) and any
regulations enacted thereunder that may result from changing
political conditions, the new administration or judicial actions;
rate cuts or other payment reductions or delays by governmental
payors and other risks and uncertainties affecting our government
businesses; our ability to adequately price products; tax matters;
disasters or major epidemics; changes in expected contract start
dates; provider, state, federal, foreign and other contract changes
and timing of regulatory approval of contracts; the expiration,
suspension, or termination of our contracts with federal or state
governments (including, but not limited to, Medicaid, Medicare,
TRICARE or other customers); the difficulty of predicting the
timing or outcome of legal or regulatory proceedings or matters,
including claims against our PBM business or whether additional
claims, reviews or investigations relating to our PBM business will
be brought by states, the federal government or shareholder
litigants, or government investigations; challenges to our contract
awards; cyber-attacks or other privacy or data security incidents;
the exertion of management's time and our resources, and other
expenses incurred and business changes required in connection with
complying with the undertakings in connection with any regulatory,
governmental or third party consents or approvals for acquisitions,
including the Magellan Acquisition; disruption caused by
significant completed and pending acquisitions making it more
difficult to maintain business and operational relationships; the
risk that unexpected costs will be incurred in connection with the
completion and/or integration of acquisition transactions; changes
in expected closing dates, estimated purchase price and accretion
for acquisitions; the risk that acquired businesses will not be
integrated successfully; restrictions and limitations in connection
with our indebtedness; our ability to maintain or achieve
improvement in the Centers for Medicare and Medicaid Services (CMS)
Star ratings and maintain or achieve improvement in other quality
scores in each case that can impact revenue and future growth;
availability of debt and equity financing, on terms that are
favorable to us; inflation; foreign currency fluctuations and risks
and uncertainties discussed in the reports that Centene has filed
with the Securities and Exchange Commission. This list of important
factors is not intended to be exhaustive. We discuss certain of
these matters more fully, as well as certain other factors that may
affect our business operations, financial condition and results of
operations, in our filings with the Securities and Exchange
Commission (SEC), including our annual report on Form 10-K,
quarterly reports on Form 10-Q and current reports on Form 8-K. Due
to these important factors and risks, we cannot give assurances
with respect to our future performance, including without
limitation our ability to maintain adequate premium levels or our
ability to control our future medical and selling, general and
administrative costs.
View original
content:https://www.prnewswire.com/news-releases/centene-names-rich-fisher-svp-and-medicare-ceo-301355674.html
SOURCE Centene Corporation